⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,839.73
−0.20%
FTSE ADX
9,848.74
+0.67%
TASI
9,970.57
−1.51%
QE Index
8,650.34
+0.20%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,961.44
+0.00%
DFM:EMIRATESNBD
AED 31.46
−0.13%
ADX:IHC
AED 359.90
+2.24%
SAU:2222
SAR 25.60
−0.78%
DSMD:QNBK
QAR 15.45
−1.34%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 302.00
+0.85%
Gold
$4,121.77
−0.46%
Brent
$111.17
+1.79%
BTC
$81,454.75
−0.47%
ETH
$2,384.56
−0.86%
DFM General
5,839.73
−0.20%
FTSE ADX
9,848.74
+0.67%
TASI
9,970.57
−1.51%
QE Index
8,650.34
+0.20%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,961.44
+0.00%
DFM:EMIRATESNBD
AED 31.46
−0.13%
ADX:IHC
AED 359.90
+2.24%
SAU:2222
SAR 25.60
−0.78%
DSMD:QNBK
QAR 15.45
−1.34%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 302.00
+0.85%
Gold
$4,121.77
−0.46%
Brent
$111.17
+1.79%
BTC
$81,454.75
−0.47%
ETH
$2,384.56
−0.86%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
AstraZeneca PLC · News · TradingHolo
Markets
›
United States
› NYSE
› AZN
A
AstraZeneca PLC
NYSE:AZN
Healthcare
—
—
At close · Market cap
—
· Next earnings
Fri 30 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
AZN news
Headlines tagged to this company
BU
AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, IMFINZI® (durvalumab), TAGRISSO® (osimertinib) and savolitinib
BusinessWire · 22 h ago
SE
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro
Seeking Alpha · 5 d ago
SE
Hospital group files lawsuit to stop 340B rebate pilot again
Seeking Alpha · 10 d ago
SE
Myriad, SOPHiA partner with AstraZeneca to use prostate cancer technology
Seeking Alpha · 12 d ago
SE
AstraZeneca CEO Soriot says drugmaker can grow without big acquisition
Seeking Alpha · 15 d ago
BU
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
BusinessWire · 15 d ago
SE
Trending stocks this week as markets weigh jobs data, yields
Seeking Alpha · 16 d ago
SE
Catalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount
seekingalpha · 25 d ago
SE
AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma
seekingalpha · 27 d ago
SE
Novo CEO says Ozempic maker is open to direct U.S. listing: FT
seekingalpha · 27 d ago
SE
Merck, Astra, Roche and Corcept among winners of EU drug recommendations this week
seekingalpha · 32 d ago
GU
AstraZeneca Gains as Enhertu Clears England's Value Gate
gurufocus · 33 d ago
SE
Astra-Daiichi breast cancer drug Enhertu recommended for NHS use in England
seekingalpha · 33 d ago
SE
BlossomHill closes up 18% on strongest day since August IPO
seekingalpha · 34 d ago
GU
AstraZeneca Shares Rise as J.P. Morgan Stays Overweight
gurufocus · 34 d ago
MA
AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears
marketbeat · 37 d ago
SE
Olema drops after hours on AstraZeneca Etcamah data
seekingalpha · 38 d ago
SE
AstraZeneca's Etcamah fails in late-stage trial as first-line breast cancer treatment
seekingalpha · 38 d ago
GU
AstraZeneca Falls 1.3% Despite a 34% COPD Breakthrough
gurufocus · 41 d ago
SE
Astra, Roche win new Outperform ratings as RBC initiates EU pharma coverage
seekingalpha · 41 d ago
More news →